RenX Enterprises Corp. (RENX): Nasdaq/NYSE listing notice — SGD receives Nasdaq bid-price deficiency notice; 180 days to cure by Oct 22, 2024

RenX Enterprises Corp.

Stock price closed below $1.00 for 30 consecutive business days (Mar 14–Apr 24, 2024).
Compliance period runs until October 22, 2024; must close at $1.00+ for 10+ consecutive days.
Previously disclosed Nasdaq equity deficiency: stockholders' equity $1.89M vs $2.5M minimum.
Company considering a reverse stock split to regain compliance.
Listing and trading of common stock (SGD) continue without immediate effect.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

RenX Enterprises Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 25, 2024, Safe and Green Development Corporation (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (March 14, 2024 through April 24, 2024), the Company’s common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trad

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

RenX Enterprises Corp. filing history →

Source: SEC EDGAR

accession 0001213900-24-036608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.